Elunetirom

N/A

Report date: 2025/12/25 15:59:29
NME

Base Information

Drug NameElunetirom
Drug Alias NameABX-002ABX 002MA-JD 21
ClassificationSmall molecules
Mechanisms of ActionThyroid hormone receptor beta-1 agonists
TargetsThyroid hormone receptor beta
Therapy Area/IndicationsDepressive Disorder, MajorMood DisordersBipolar Disorder
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAutobahn Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesAutobahn Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsDepressive Disorder, MajorMood DisordersBipolar Disorder
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A